Thiourea and Guanidine Compounds and Their Iridium Complexes in Drug-Resistant Cancer Cell Lines : Structure-Activity Relationships and Direct Luminescent Imaging
© 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim..
Thiourea and guanidine units are found in nature, medicine, and materials. Their continued exploration in applications as diverse as cancer therapy, sensors, and electronics means that their toxicity is an important consideration. Iridium complexes present new opportunities for drug development and imaging in terms of structure and photoactivity. We have systematically synthesised a set of thiourea and guanidine compounds and iridium complexes thereof, and elucidated structure-activity relationships for cellular toxicity in three ovarian cancer cell lines and their cisplatin-resistant sub-lines. We have been able to use the intrinsic luminescence of iridium complexes to visualise the effect of both structure alteration and cellular resistance mechanisms. These findings provide starting points for the development of new drugs and consideration of safety issues for novel thiourea-, guanidine-, and iridium-based materials.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:15 |
---|---|
Enthalten in: |
ChemMedChem - 15(2020), 4 vom: 17. Feb., Seite 349-353 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Thomas, Samuel J [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 08.02.2021 Date Revised 08.02.2021 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1002/cmdc.201900591 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM304301299 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM304301299 | ||
003 | DE-627 | ||
005 | 20231225114708.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1002/cmdc.201900591 |2 doi | |
028 | 5 | 2 | |a pubmed24n1014.xml |
035 | |a (DE-627)NLM304301299 | ||
035 | |a (NLM)31828886 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Thomas, Samuel J |e verfasserin |4 aut | |
245 | 1 | 0 | |a Thiourea and Guanidine Compounds and Their Iridium Complexes in Drug-Resistant Cancer Cell Lines |b Structure-Activity Relationships and Direct Luminescent Imaging |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 08.02.2021 | ||
500 | |a Date Revised 08.02.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. | ||
520 | |a Thiourea and guanidine units are found in nature, medicine, and materials. Their continued exploration in applications as diverse as cancer therapy, sensors, and electronics means that their toxicity is an important consideration. Iridium complexes present new opportunities for drug development and imaging in terms of structure and photoactivity. We have systematically synthesised a set of thiourea and guanidine compounds and iridium complexes thereof, and elucidated structure-activity relationships for cellular toxicity in three ovarian cancer cell lines and their cisplatin-resistant sub-lines. We have been able to use the intrinsic luminescence of iridium complexes to visualise the effect of both structure alteration and cellular resistance mechanisms. These findings provide starting points for the development of new drugs and consideration of safety issues for novel thiourea-, guanidine-, and iridium-based materials | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a OLEDs | |
650 | 4 | |a cancer | |
650 | 4 | |a cellular imaging | |
650 | 4 | |a drug resistance | |
650 | 4 | |a metal complexes | |
650 | 7 | |a Antineoplastic Agents |2 NLM | |
650 | 7 | |a Coordination Complexes |2 NLM | |
650 | 7 | |a Iridium |2 NLM | |
650 | 7 | |a 44448S9773 |2 NLM | |
650 | 7 | |a Thiourea |2 NLM | |
650 | 7 | |a GYV9AM2QAG |2 NLM | |
650 | 7 | |a Guanidine |2 NLM | |
650 | 7 | |a JU58VJ6Y3B |2 NLM | |
700 | 1 | |a Balónová, Barbora |e verfasserin |4 aut | |
700 | 1 | |a Cinatl, Jindrich |c Jr |e verfasserin |4 aut | |
700 | 1 | |a Wass, Mark N |e verfasserin |4 aut | |
700 | 1 | |a Serpell, Christopher J |e verfasserin |4 aut | |
700 | 1 | |a Blight, Barry A |e verfasserin |4 aut | |
700 | 1 | |a Michaelis, Martin |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t ChemMedChem |d 2006 |g 15(2020), 4 vom: 17. Feb., Seite 349-353 |w (DE-627)NLM164619577 |x 1860-7187 |7 nnns |
773 | 1 | 8 | |g volume:15 |g year:2020 |g number:4 |g day:17 |g month:02 |g pages:349-353 |
856 | 4 | 0 | |u http://dx.doi.org/10.1002/cmdc.201900591 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 15 |j 2020 |e 4 |b 17 |c 02 |h 349-353 |